Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Oct / Label-Free Virtual Staining and Cancer Classification
Histology Histology Digital and computational pathology

Label-Free Virtual Staining and Cancer Classification

How a deep learning method automates histology imaging processes, achieving 98 percent accuracy in cancer diagnosis – without traditional dyes

By Jessica Allerton 10/21/2024 News 2 min read

Share

Researchers have developed a new deep learning-based framework that enables virtual staining, segmentation, and classification of histological images without the need for traditional dyes. The approach, centered around photoacoustic histology (PAH), offers a label-free alternative to standard hematoxylin and eosin (H&E) staining – a critical technique for pathological diagnostics but hindered by its labor-intensive processes.

The study integrates three deep learning methodologies into a unified system. First, the team introduces the Explainable Contrastive Unpaired Translation method, which virtually stains grayscale PAH images, transforming them into near-perfect replicas of H&E-stained images. This model preserves critical morphological details, such as cell nuclei and cytoplasm, enhancing the interpretability and traceability of the stained images.

Next, in the segmentation step, a U-Net architecture model segments features, such as cell area, cell count, and intercellular distance within the stained images. These features are essential in distinguishing between noncancerous and cancerous tissues – providing a quantitative foundation for further classification. The segmentation achieved significant accuracy in this study; however, slight discrepancies in cell area measurements were noted in cancerous tissues due to the limitations of PAH images.

Finally, the framework’s Stepwise Feature Fusion method combines features extracted from PAH, virtually stained H&E, and segmented images to achieve a classification accuracy of 98 percent. This outperformed conventional PAH classification, which had a 95 percent accuracy. The model’s sensitivity reached 100 percent, as verified by three pathologists, underscoring its potential for use in clinical settings.

This interconnected deep learning framework, capable of performing automated virtual staining, segmentation, and classification, offers a promising solution for digital pathology. Its high accuracy and automated nature could significantly reduce the time and labor involved in histopathological diagnostics – potentially improving intraoperative decision-making processes.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Your Newest Colleague?
Histology
Your Newest Colleague?

January 6, 2022

1 min read

The need for AI-based end-to-end biomarkers in oncology

Biospecimen Access For Biotechs
Histology
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Case of the Month
Histology
Case of the Month

February 21, 2022

1 min read

The Art of the Laboratory
Histology
The Art of the Laboratory

March 25, 2022

1 min read

For the seventh time, we asked you to share the images you think capture the most beautiful, educational, or amusing aspects of pathology – and you delivered. Welcome to our gallery tour of the most visually striking discipline in medicine!

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.